Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP‐BD)
Jane N. Kogan(Harvard University), Joseph R. Calabrese(University Hospitals of Cleveland), Mark S. Bauer(Harvard University), Terence A. Ketter(Universidade Federal do Rio Grande do Sul), Matthew V. Rudorfer(National Institute of Mental Health), Stephen R. Wisniewski, Michael W. Otto(Harvard University), David J. Miklowitz, Hongwei Zhang(Shandong University), Ellen B. Dennehy(Eli Lilly (United States)), Michael E. Thase(The University of Texas at San Antonio Health Science Center)
Cited by 121
Related Papers
Effectiveness-implementation Hybrid Designs
|Medical Care|2012|4.2k
An introduction to implementation science for the non-specialist
|BMC Psychology|2015|2k
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder
|Nature Genetics|2008|1.3k
Implementation science: What is it and why should I care?
|Psychiatry Research|2019|1.2k